北京大豪科技股份有限公司2025 年半年度报告 公司代码：603025 公司简称：大豪科技 北京大豪科技股份有限公司 2025 年半年度报告 1 / 151 北京大豪科技股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人胡雄光、主管会计工作负责人周斌及会计机构负责人（会计主管人员）周斌声 明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的发展战略及规划等前瞻性描述不构成公司对投资者的实质承诺，敬请投资 者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 报告期 ...

四川川投能源股份有限公司2025 年半年度报告 公司代码：600674 公司简称：川投能源 四川川投能源股份有限公司 2025 年半年度报告 1 / 208 四川川投能源股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人吴晓曦、主管会计工作负责人刘好及会计机构负责人（会计主管人员）秦乙可 声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告中所涉及的未来计划、发展战略等前瞻性描述不构成公司对投资者的实质承诺，敬请 投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 ...

湖南航天环宇通信科技股份有限公司2025 年半年度报告 公司代码：688523 公司简称：航天环宇 湖南航天环宇通信科技股份有限公司 2025 年半年度报告 1 / 202 湖南航天环宇通信科技股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中描述公司可能面临的主要风险，敬请查阅本报告第三节"管理层讨论与分 析"中"四、风险因素"部分相关内容，请投资者予以关注。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人李完小、主管会计工作负责人詹枞生及会计机构负责人（会计主管人员）李殊 姝声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 √适用 □不适用 本报告内容涉及的未来计划、发展战略等前瞻性陈述存在不确定性，不构成公司对投资者的 ...

西南证券股份有限公司2025 年半年度报告 公司代码：600369 公司简称：西南证券 西南证券股份有限公司 2025 年半年度报告 1 / 178 西南证券股份有限公司2025 年半年度报告 三、本半年度报告未经审计。 四、公司负责人姜栋林、主管会计工作负责人张序及会计机构负责人（会计主管人员）孟蓓声明： 保证半年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司2025年半年度利润分配方案为：以截至2025年6月30日总股本6,645,109,124股为基数，向 全体股东每10股派发现金红利0.1元（含税），实际分配现金利润66,451,091.24元。 根据公司2024年年度股东大会审议通过的《关于公司2024年年度利润分配预案和2025年中期 利润分配授权的议案》，本方案符合中期利润分配的条件且中期派发现金红利总额未超过公司2025 年相应期间归属于母公司股东的净利润，无需提交公司股东大会审议。 六、前瞻性陈述的风险声明 √适用 □不适用 本半年度报告中涉及未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺， 敬请投资者注意投资风险。 重 ...

江苏浩欧博生物医药股份有限公司2025 年半年度报告 重要提示 江苏浩欧博生物医药股份有限公司2025 年半年度报告 公司代码：688656 公司简称：浩欧博 江苏浩欧博生物医药股份有限公司 2025 年半年度报告 1 / 217 四、 本半年度报告未经审计。 五、 公司负责人JOHN LI、主管会计工作负责人张扬清及会计机构负责人（会计主管人员）韩书 艳声明：保证半年度报告中财务报告的真实、准确、完整。 六、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 不适用 七、 是否存在公司治理特殊安排等重要事项 □适用 √不适用 八、 前瞻性陈述的风险声明 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 公司已在本报告中详细阐述公司在经营过程中可能面临的各种风险，敬请查阅本 报告第三节"管理层讨论与分析"中"四、风险因素"的相关内容。 三、 公司全体董事出席董事会会议。 √适用 □不适用 本报告所涉及的公司未来计划、发展战略等前瞻性陈述，不构成公司对投资者的 实质承诺 ...

[Company Profile and Key Financial Indicators](index=7&type=section&id=Company%20Profile%20and%20Key%20Financial%20Indicators) This section provides an overview of the company's basic information and presents its key accounting data and financial performance indicators [Company Overview](index=7&type=section&id=Company%20Overview) Xi'an Kaili New Materials Co., Ltd. (Kaili New Materials, 688269) is a new materials company led by Zeng Yongkang, registered and operating in Xi'an Economic and Technological Development Zone, Shaanxi Province - Company's Chinese name is Xi'an Kaili New Materials Co., Ltd., stock code **688269**, listed on the STAR Market of Shanghai Stock Exchange[13](index=13&type=chunk)[16](index=16&type=chunk) - Mr. Zeng Yongkang has been appointed as the legal representative of the company[13](index=13&type=chunk) [Key Accounting Data and Financial Indicators](index=8&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) During the reporting period, the company achieved operating revenue of **1.014 billion yuan**, a **24.86%** increase, and net profit attributable to parent of **61.2 million yuan**, up **30.83%**, driven by increased catalyst sales and optimized business structure, though net cash flow from operating activities significantly decreased to **-91.18 million yuan** due to increased receivables and raw material purchases Key Accounting Data (yuan) | Key Accounting Data | Current Period (Jan-Jun) | Prior Period | Year-on-Year Change (%) | | :--- | :--- | :--- | :--- | | **Operating Revenue** | 1,014,440,234.28 | 812,448,045.42 | 24.86 | | **Net Profit Attributable to Shareholders of Listed Company** | 61,195,291.25 | 46,776,124.61 | 30.83 | | **Net Profit Attributable to Shareholders of Listed Company After Deducting Non-Recurring Gains and Losses** | 63,294,359.78 | 42,552,326.99 | 48.74 | | **Net Cash Flow from Operating Activities** | -91,179,720.04 | 35,190,791.64 | -359.10 | Key Financial Indicators | Key Financial Indicators | Current Period (Jan-Jun) | Prior Period | Year-on-Year Change (%) | | :--- | :--- | :--- | :--- | | **Basic Earnings Per Share (yuan/share)** | 0.47 | 0.36 | 30.56 | | **Basic Earnings Per Share After Deducting Non-Recurring Gains and Losses (yuan/share)** | 0.48 | 0.33 | 45.45 | | **Weighted Average Return on Net Assets (%)** | 5.86 | 4.62 | Increased by 1.24 percentage points | | **R&D Investment as Percentage of Operating Revenue (%)** | 2.34 | 2.72 | Decreased by 0.38 percentage points | - Operating revenue growth primarily due to a **122.33% year-on-year increase** in overall catalyst product sales, with sales in the pharmaceutical and basic chemical sectors growing by **49.26%** and **185.54%** respectively[19](index=19&type=chunk) - Net cash flow from operating activities significantly decreased by **359.10%**, mainly due to increased accounts receivable from expanded sales and higher raw material procurement expenses to meet production orders[22](index=22&type=chunk) [Management Discussion and Analysis](index=10&type=section&id=Management%20Discussion%20and%20Analysis) This section provides an in-depth discussion of the company's industry position, operational performance, core competencies, and key risk factors [Industry and Main Business](index=10&type=section&id=Description%20of%20Industry%20and%20Main%20Business%20During%20the%20Reporting%20Period) The company, a leading precious metal catalyst enterprise in fine chemicals, expanded into basic chemicals and environmental new energy, achieving significant sales growth of **49.26%** in pharmaceuticals, **185.54%** in basic chemicals, and **1497.06%** in environmental new energy - The company is a leader and technology pioneer in precious metal catalysts within the fine chemical sector, with business synergistically developing around "catalyst preparation and catalytic application technology", forming three major business segments: R&D and production, technology development, and recycling and reprocessing[27](index=27&type=chunk) - During the reporting period, the company achieved significant sales growth across all major business areas: - **Pharmaceutical Sector**: Sales increased by **49.26%** year-on-year, primarily due to increased demand from core customers and enhanced market share[29](index=29&type=chunk) - **Basic Chemical Sector**: Sales increased by **185.54%** year-on-year, mainly benefiting from a **113.22%** increase in PVC mercury-free catalyst sales and new product promotion[30](index=30&type=chunk) - **Environmental New Energy Sector**: Sales surged by **1497.06%** year-on-year, primarily due to significant progress in hydrogen energy catalysts and establishing partnerships with leading water electrolysis hydrogen production enterprises[32](index=32&type=chunk) [Discussion and Analysis of Operations](index=12&type=section&id=Discussion%20and%20Analysis%20of%20Operations) In H1 2025, the company made significant progress in strategy, R&D, marketing, and production, forming a "three locations, four zones" synergistic development pattern, advancing R&D digitalization, expanding market reach, and enhancing operational efficiency through automation - **Strategic Layout**: The company has formed a "Caotan, Jingwei, Tongchuan, Binzhou" three locations, four zones synergistic development pattern. The main construction of the Binzhou Kaitai Hydrogenated Nitrile Butadiene Rubber industrialization project has been completed and entered the commissioning phase[35](index=35&type=chunk) - **Technology R&D**: In H1 2025, **23 new invention patent applications** were filed, with a cumulative total of **191 authorized patents**. The company strengthened R&D digitalization, utilizing AI simulation and prediction to guide catalyst R&D[36](index=36&type=chunk)[37](index=37&type=chunk) - **Market Marketing**: While consolidating its leading position in fine chemicals, sales in the basic chemical sector increased by **185.54%** year-on-year. The company is also accelerating its global layout, actively collaborating with overseas customers[38](index=38&type=chunk)[39](index=39&type=chunk) - **Production Operations**: Multiple automated demonstration production lines were established, and the automation upgrade of the PVC mercury-free catalyst carbon carrier treatment production line was completed, enhancing operational efficiency[39](index=39&type=chunk)[40](index=40&type=chunk) [Analysis of Core Competencies](index=14&type=section&id=Analysis%20of%20Core%20Competencies%20During%20the%20Reporting%20Period) The company's core competencies span six areas: institutional mechanisms, technology R&D, products, talent, brand and customer base, and service advantages, with continuous R&D investment, **23.75 million yuan** in expensed R&D in H1, and **173** cumulative invention patents, focusing on cutting-edge projects to address "bottleneck" issues and achieve import substitution - Company's core competencies include: 1. **Institutional Mechanism Advantage**: State-controlled background with core employee stock ownership[43](index=43&type=chunk) 2. **Technology and R&D Advantage**: Synergistic development of catalyst and catalytic application technology, possessing national-level research platforms[44](index=44&type=chunk) 3. **Product Advantage**: Comprehensive product range with excellent performance, covering fine chemicals, basic chemicals, energy, and environmental protection[46](index=46&type=chunk) 4. **Talent Advantage**: Stable and professional core management and technical team[47](index=47&type=chunk) 5. **Brand and Customer Advantage**: Nearly a thousand users, including a hundred listed companies, with high brand recognition[49](index=49&type=chunk) 6. **Service Advantage**: Provides integrated full-process services from R&D and production to recycling[49](index=49&type=chunk) - New progress in core technologies, including the activation of advanced scientific research systems introducing AI simulation and prediction, development of new platinum-carbon and ruthenium-based catalysts, breakthroughs in precious metal valence state control technology, and collaboration with Dalian Institute of Chemical Physics, Chinese Academy of Sciences on single-atom catalysts[50](index=50&type=chunk) R&D Investment | R&D Investment | Current Period (yuan) | Prior Period (yuan) | Change (%) | | :--- | :--- | :--- | :--- | | **Expensed R&D Investment** | 23,753,649.66 | 22,120,503.73 | 7.38 | | **Total R&D Investment** | 23,753,649.66 | 22,120,503.73 | 7.38 | | **Total R&D Investment as Percentage of Operating Revenue (%)** | 2.34 | 2.72 | Decreased by 0.38 percentage points | - As of the end of the reporting period, the company has cumulatively obtained **173 invention patents** and **16 utility model patents**. During the reporting period, **23 new invention patent applications** were filed, and **4 were granted**[54](index=54&type=chunk)[55](index=55&type=chunk) [Risk Factors](index=26&type=section&id=Risk%20Factors) The company faces core risks from rapid technological iteration and competitive gaps, operational risks from volatile precious metal prices and high capital occupation, and financial risks including accounts receivable impairment and gross margin fluctuations, alongside industry-specific precious metal resource scarcity and macroeconomic policy changes - **Core Competitiveness Risk**: The industry experiences rapid technological upgrades and iterations; if the company fails to continuously maintain technological advancement, it may face risks of declining competitiveness[69](index=69&type=chunk)[70](index=70&type=chunk) - **Operational Risk**: Platinum group precious metals, as primary raw materials, are subject to significant price fluctuations and high costs, accounting for over **90%** of production costs, posing challenges to the company's cost and inventory management. Downstream pharmaceutical customers are affected by policies like "4+7" volume-based procurement, which may demand cost reductions or new process development, placing higher requirements on the company's products[71](index=71&type=chunk)[72](index=72&type=chunk) - **Financial Risk**: At the end of the reporting period, the book value of accounts receivable increased, intensifying working capital occupation and bad debt risks. Concurrently, changes in business structure and raw material costs may lead to gross margin fluctuations[74](index=74&type=chunk) - **Industry Risk**: China's platinum group metal resources are scarce, primarily relying on imports; if international political factors affect supply, it will significantly impact the company's production and operations[75](index=75&type=chunk) [Analysis of Key Operating Performance](index=29&type=section&id=Key%20Operating%20Performance%20During%20the%20Reporting%20Period) During the reporting period, operating revenue and cost increased by **24.86%** and **22.58%** respectively, while financial expenses surged by **238.97%** due to increased short-term borrowings for raw material procurement; accounts receivable and financing receivables grew significantly, reflecting expanded sales and enhanced collection management, with Tongchuan Kaili contributing significantly to profit Key Operating Data (yuan) | Item | Current Period | Prior Period | Change (%) | | :--- | :--- | :--- | :--- | | **Operating Revenue** | 1,014,440,234.28 | 812,448,045.42 | 24.86 | | **Operating Cost** | 892,657,605.31 | 728,200,539.69 | 22.58 | | **Financial Expenses** | 6,970,526.86 | 2,056,372.86 | 238.97 | | **Net Cash Flow from Operating Activities** | -91,179,720.04 | 35,190,791.64 | -359.10 | - Financial expenses increased by **238.97%** year-on-year, primarily due to increased short-term borrowings for raw material procurement during the reporting period, leading to higher interest expenses[79](index=79&type=chunk) Assets/Liabilities Items (yuan) | Asset/Liability Item | Current Period End | Prior Period End | Change (%) | | :--- | :--- | :--- | :--- | | **Accounts Receivable** | 227,181,414.79 | 155,833,042.87 | 45.79 | | **Accounts Receivable Financing** | 105,160,602.64 | 56,777,284.20 | 85.22 | | **Long-term Borrowings** | 150,250,215.91 | 115,000,000.00 | 30.65 | - As of the end of the reporting period, the company's total restricted assets amounted to **405 million yuan**, mainly comprising fixed assets, intangible assets, and construction in progress pledged for borrowings[84](index=84&type=chunk)[85](index=85&type=chunk) [Corporate Governance, Environment, and Society](index=36&type=section&id=Corporate%20Governance%2C%20Environment%2C%20and%20Society) This section details changes in the company's board, senior management, and core technical personnel [Changes in Directors, Supervisors, Senior Management, and Core Technical Personnel](index=36&type=section&id=Changes%20in%20Company%20Directors%2C%20Senior%20Management%2C%20and%20Core%20Technical%20Personnel) During the reporting period, the company experienced several senior personnel changes, including Mr. Zhang Zhixiang's retirement as Chairman, succeeded by Mr. Zeng Yongkang, and Ms. Wang Shihong's resignation as CFO and Board Secretary, succeeded by Mr. Zeng Lihui, with no changes in core technical personnel - Mr. Zhang Zhixiang resigned as Chairman due to retirement but continues to serve as a core technical personnel[93](index=93&type=chunk) - Mr. Zeng Yongkang was elected as the new Chairman and became the company's legal representative[93](index=93&type=chunk) - Mr. Zeng Lihui was appointed as Deputy General Manager, Chief Financial Officer, and Board Secretary[93](index=93&type=chunk)[94](index=94&type=chunk) [Significant Matters](index=38&type=section&id=Significant%20Matters) This section outlines the fulfillment of commitments, significant related party transactions, and major contracts and their performance [Fulfillment of Commitments](index=38&type=section&id=Fulfillment%20of%20Commitments) During the reporting period, the company's actual controller, shareholders, related parties, and the company itself strictly adhered to all commitments made during the initial public offering, including share lock-up, holding intentions, avoidance of horizontal competition, and standardization of related party transactions, with no violations - Commitments made by the company's controlling shareholder Northwest Institute, directors, senior management, and core technical personnel, such as share lock-up, were timely and strictly fulfilled during or continuing into the reporting period[101](index=101&type=chunk)[102](index=102&type=chunk)[103](index=103&type=chunk) [Significant Related Party Transactions](index=59&type=section&id=Significant%20Related%20Party%20Transactions) During the reporting period, the company engaged in daily operational related party transactions, including sales of products and services totaling **23.65 million yuan** to Xi'an Taijin New Energy Technology Co., Ltd. and **4.15 million yuan** to Western Metal Materials Co., Ltd., all within the estimated amounts Related Party Transaction Categories | Related Party Transaction Category | Related Party | Estimated Amount (million yuan) | Actual Amount During Reporting Period (million yuan) | | :--- | :--- | :--- | :--- | | **Sales of Products, Goods, and Services to Related Parties** | Xi'an Taijin New Energy Technology Co., Ltd. and its controlled companies | 6,000.00 | 2,365.39 | | | Western Metal Materials Co., Ltd. and its controlled companies | 4,000.00 | 414.91 | | | Northwest Institute for Non-ferrous Metal Research, the company's controlling shareholder, and its controlled companies | 500.00 | 230.14 | | **Acceptance of Services from Related Parties** | Northwest Institute for Non-ferrous Metal Research, the company's controlling shareholder, and its controlled companies | 285.00 | 133.64 | [Significant Contracts and Their Fulfillment](index=61&type=section&id=Significant%20Contracts%20and%20Their%20Fulfillment) During the reporting period, the company provided joint liability guarantees totaling up to **400 million yuan** for its wholly-owned subsidiary Tongchuan Kaili, with a remaining guarantee balance of **81.75 million yuan** at period-end, representing **8.11%** of net assets, all within approved limits and without overdue external guarantees - The company provided two guarantees for its wholly-owned subsidiary Tongchuan Kaili, totaling **130 million yuan**, for working capital and fixed asset borrowings[130](index=130&type=chunk) - At the end of the reporting period, the total guarantee balance for subsidiaries was **81.75 million yuan**, representing **8.11%** of the company's net assets[130](index=130&type=chunk) [Share Changes and Shareholder Information](index=65&type=section&id=Share%20Changes%20and%20Shareholder%20Information) This section details the company's shareholder structure and key shareholder information [Shareholder Information](index=65&type=section&id=Shareholder%20Information) As of the end of the reporting period, the company had **5,848** common shareholders, with the top ten shareholder structure remaining stable, and controlling shareholder Northwest Institute for Non-ferrous Metal Research holding **25.71%**, alongside core management and institutional investors like social security and pension funds - As of the end of the reporting period, the company had a total of **5,848** common shareholders[136](index=136&type=chunk) Shareholder Information | Shareholder Name | Shares Held at Period End | Percentage (%) | | :--- | :--- | :--- | | Northwest Institute for Non-ferrous Metal Research | 33,600,000 | 25.71 | | Zhang Zhixiang | 5,506,632 | 4.21 | | Huatai-PineBridge Fund Management Co., Ltd. - Social Security Fund 17022 Portfolio | 3,390,598 | 2.59 | | Basic Pension Insurance Fund 16032 Portfolio | 1,996,684 | 1.53 | | Wang Pengbao | 1,755,800 | 1.34 | [Financial Report](index=70&type=section&id=Financial%20Report) This section presents the company's consolidated financial statements and selected notes, providing a detailed view of its financial position and performance [Consolidated Financial Statements](index=70&type=section&id=Consolidated%20Financial%20Statements) As of June 30, 2025, the company's total assets were **2.164 billion yuan**, up **5.50%** from the beginning of the period, with total liabilities of **1.114 billion yuan**, operating revenue of **1.014 billion yuan**, and net profit of **61.13 million yuan**, while operating cash flow was a net outflow of **91.18 million yuan** and financing cash flow a net inflow of **83.54 million yuan** Balance Sheet Items (yuan) | Balance Sheet Item | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Total Assets** | 2,164,106,653.29 | 2,051,340,758.70 | | **Total Liabilities** | 1,114,456,952.16 | 999,321,050.54 | | **Total Equity Attributable to Parent Company Owners** | 1,007,544,973.82 | 1,013,485,099.31 | Income Statement Items (yuan) | Income Statement Item | H1 2025 | H1 2024 | | :--- | :--- | :--- | | **Total Operating Revenue** | 1,014,440,234.28 | 812,448,045.42 | | **Total Operating Cost** | 949,209,029.82 | 774,611,538.17 | | **Total Profit** | 69,075,853.22 | 51,426,288.86 | | **Net Profit** | 61,125,409.71 | 46,747,372.85 | Cash Flow Statement Items (yuan) | Cash Flow Statement Item | H1 2025 | H1 2024 | | :--- | :--- | :--- | | **Net Cash Flow from Operating Activities** | -91,179,720.04 | 35,190,791.64 | | **Net Cash Flow from Investing Activities** | -77,892,281.49 | -204,531,931.44 | | **Net Cash Flow from Financing Activities** | 83,535,800.37 | 139,032,604.15 | [Notes to Financial Statements (Excerpt)](index=117&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Financial statement notes detail account composition and changes, including **230 million yuan** in cash and equivalents (with **12.1 million yuan** restricted), **227 million yuan** in accounts receivable (up **45.79%**), **338 million yuan** in inventory, and operating revenue primarily from catalyst sales, with **23.75 million yuan** in expensed R&D - Cash and equivalents at period-end totaled **230 million yuan**, of which **12.1 million yuan** was restricted as bank guarantee deposits[286](index=286&type=chunk) - Accounts receivable at period-end had a book balance of **240 million yuan**, with a book value of **227 million yuan** after deducting **12.47 million yuan** for bad debt provisions[295](index=295&type=chunk)[298](index=298&type=chunk) Operating Revenue Composition (yuan) | Operating Revenue Composition | Revenue (yuan) | Cost (yuan) | | :--- | :--- | :--- | | **Main Business** | 941,830,136.94 | 822,391,027.08 | | Of which: Catalyst Sales | 873,814,904.71 | 792,148,143.05 | | Catalyst Processing | 67,676,536.82 | 30,160,369.20 | | **Other Business** | 72,610,097.34 | 70,266,578.23 | | **Total** | 1,014,440,234.28 | 892,657,605.31 | - Total R&D expenses during the reporting period were **23,753,649.66 yuan**, primarily comprising employee compensation (**10.78 million yuan**) and material costs (**6.52 million yuan**), all expensed[419](index=419&type=chunk)[446](index=446&type=chunk)

北京诺禾致源科技股份有限公司2025 年半年度报告 公司代码：688315 公司简称：诺禾致源 北京诺禾致源科技股份有限公司 2025 年半年度报告 1 / 196 北京诺禾致源科技股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 重大风险提示 报告期内，不存在对公司生产经营产生实质性影响的特别重大风险，并已在本报告中详细阐 述在公司生产经营过程中可能面临的风险及应对措施，敬请查阅本报告第三节"管理层讨论与分 析"之"四、风险因素"部分内容。 三、 公司全体董事出席董事会会议。 四、 本半年度报告未经审计。 五、 公司负责人李瑞强、主管会计工作负责人施加山及会计机构负责人（会计主管人员）陈伟 声明：保证半年度报告中财务报告的真实、准确、完整。 √适用 □不适用 本报告所涉及的公司未来计划、发展战略等前瞻性陈述，不构成公司对投资者的实质承诺， 请投资者保持足够的风险防范意识，并且应当理解计划、预测与实际之间的差异，注意投资风险。 九、 是否存在被 ...

1 / 138 江西赣粤高速公路股份有限公司2025 年半年度报告 公司代码：600269 公司简称：赣粤高速 江西赣粤高速公路股份有限公司 2025 年半年度报告 江西赣粤高速公路股份有限公司2025 年半年度报告 重要提示 三、 本半年度报告未经审计。 一、 本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确 性、完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 四、 公司负责人韩峰先生、主管会计工作负责人徐义标先生及会计机构负责人（会计主管人员） 焦婷女士声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告所涉及未来计划、公司战略等前瞻性陈述，不构成公司对投资者的实质承诺，请投资 者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十 ...

苏州西典新能源电气股份有限公司2025 年半年度报告 公司代码：603312 公司简称：西典新能 苏州西典新能源电气股份有限公司 2025 年半年度报告 1 / 177 苏州西典新能源电气股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人盛建华、主管会计工作负责人李玉红及会计机构负责人（会计主管人员）赵国 静声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 公司第二届董事会第九次会议，审议通过《关于公司2025年中期利润分配预案的议案》，拟 以公司 2025年中期利润分配实施股权登记日的总股本为基数（扣除公司回购专用证券账户中的股 份），向全体股东每10股派发现金红利4.00元（含税），共计派发人民币62,738,732.00元（含税 ），不送红股，不进行资本公积金转增股本，现金分红占2025年半年度合并报表归属于上市 ...

重庆啤酒股份有限公司2025 年半年度报告 公司代码：600132 公司简称：重庆啤酒 重庆啤酒股份有限公司 2025 年半年度报告 1 / 161 重庆啤酒股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性，不 存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人João Miguel Ventura Rego Abecasis、主管会计工作负责人Chin Wee Hua及会 计机构负责人（会计主管人员）刘莉萍声明：保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 √适用 □不适用 本报告涉及未来计划等前瞻性陈述，该等陈述不构成公司对投资者的实质承诺，请投资者注意投 资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真 ...